POSTER SESSION III
Tuesday, March 20, 2012   9:30 AM - 12:00 Noon
CC Exhibit Hall B3 & C
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
BONE & SOFT TISSUE PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
1
Extraskeletal Myxoid Chondrosarcoma Presenting as a Primary Bone Tumor: Four Cases with Molecular Confirmation
(33)
EG Demicco, W-L Wang, JA Bridge, D Huang, JE Madewell, JM Meis - The University of Texas M. D. Anderson Cancer Center, Houston, TX; University of Nebraska Medical Center, Omaha, NE
The Benign Notochordal Cell Tumor and Ecchordosis Physaliphora Lack the Complex Genomic and Genetic Alterations Commonly Found in the Conventional Chordomas
(54)
YD Lee, LP Le, V Deshpande, AJ Iafrates, AE Rosenberg, GP Nielsen - Massachusetts General Hospital, Boston, MA; University of Miami, Miami
Chordoma Arising in Benign Notochordal Cell Tumor: A Detailed Radiological, Gross and Microscopic Description of Three Cases Involving the Lumbar Spine
(46)
SEA Ishak, GP Nielsen, AE Rosenberg - Cairo University, Cairo, Egypt; Massachusetts General Hospital, Boston, MA; University of Miami, Miami, FL
MicroRNA Profiles in Osteosarcoma
(83)
KY Won, YW Kim, Y-K Park - Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Republic of Korea; Kyung Hee Medical Center, College of Medicine, Kyung Hee University, Seoul, Republic of Korea
Osteosarcoma of the Hands and Feet: A Clinico-Pathologic Distinct Subgroup of OS?
(18)
JK Anninga, P Picci, HM Kroon, D Vanel, PCW Hogendoorn - Leiden University Medical Center, Leiden, Netherlands; Istituto Ortopedico Rizzoli, Bologna, Italy
Gene Deletion Underlies Loss of P16 Expression in Osteosarcoma Tumors with Poor Response to Neoadjuvant Chemotherapy
(22)
D Borys, R Canter, J Gregg, B Hoch, R Davis, A Horvai - University of California Davis, Sacramento; UC Davis, Sacramento; University of Washington, Seattle; UCSF, San Francisco
Evaluation of the Mitogen-Activated Protein Kinase Pathway in Osteosarcoma
(61)
KY Na, YW Kim, Y-K Park - Kyung Hee University Hospital, Seoul, Republic of Korea
Molecular Distinction of Chondrosarcoma from Chondroblastic Osteosarcoma through IDH12 Mutations
(50)
DA Kerr, V Deshpande, DR Borger, GP Nielsen - Massachusetts General Hospital, Boston, MA
Interobserver Reliability in the Histopathological Diagnosis of Peripheral Cartilaginous Tumors in Patients with Multiple Osteochondromas: How Can We Improve Diagnostic Quality?
(32)
CE de Andrea, HM Kroon, R Wolterbeek, S Romeo, AE Rosenberg, BR DeYoung, B Liegl-Atzwanger, CY Inwards, E Hauben, EF McCarthy, M Idoate, NA Athanasou, KB Jones, PCW Hogendoorn, JVMG Bovee - Leiden University Medical Center, Leiden, Netherlands; Treviso Regional Hospital, Treviso, Italy; Massachusetts General Hospital, Boston; University of Iowa Carver College of Medicine, Iowa City; Medical University of Graz, Graz, Austria; Mayo Clinic, Rochester; University Hospitals Leuven, Leuven, Belgium; Johns Hopkins Hospital and Johns Hopkins University School of Medicine, Baltimore; University of Navarra, Pamplona, Spain; University of Oxford, Nuffield Orthopaedic Centre, Oxford, United Kingdom; University of Utah, Salt Lake City
Bone and Soft Tissue Pathology Discovered in Bone Bank Donors: An Analysis of 109 Lesions
(42)
SS Giobbe, BL Hoch - University of Washington, Seattle, WA
Histidine Decarboxylase Expression by Immature Myeloid Cells May Affect Peak Bone Density in Mice
(37)
J Dunlap, E Larson, J Hebert, R Klein, T Morgan - OHSU, Portland